First Tracks Biotherapeutics, Inc. (TRAX) at a glance

First Tracks Biotherapeutics, Inc. (TRAX) is a small-cap Healthcare company. It trades at $41.45, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 48/100 overall. Its strongest dimension is Momentum (69/100) and its weakest is Value (40/100).

Price

$41.45

Market cap

$1.50B

P/E ratio

n/a

Dividend yield

None

Beta

n/a

52-week range

$14.72 to $49.91